Patent ID: 8273738

Claim:
An imidazole derivative selected from the group consisting of: 5-(2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl)-N,N-diethyl-2-fluorobenzamide; 3-(2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl)-N,N-diethylbenzamide; 3-(2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl)-N-ethyl-N-methylbenzamide; 5-(2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl)-N,N-diethylnicotinamide; 4-[2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl]-N-ethyl-N-methylthiophene-2-carboxamide; 6-[2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl]-N,N-diethylpyrazine-2-carboxamide; 6-[2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl]-N-methyl-N-propylpyrazine-2-carboxamide; 6-[2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl]-N-ethyl-N-methylpyrazine-2-carboxamide; 6-[2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl]-N,N-dimethylpyrazine-2-carboxamide; 6-[2-tert-Butyl-1-(4-fluorotetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl]-N-ethyl-N-methylpyrazine-2-carboxamide; 6-[2-tert-Butyl-1-(4-fluorotetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl]-N,N-dimethylpyrazine-2-carboxamide; and 5-[2-tert-Butyl-1-(tetrahydropyran-4-ylmethyl)-1H-imidazol-4-yl]-N-methyl-N-(2,2,2-trifluoroethyl)isoxazole-3-carboxamide; or a pharmaceutically acceptable salt thereof.